ClinicalTrials.gg

AstraZeneca clinical trials

Also known as AZ.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 4,195 studies whose lead sponsor is AstraZeneca or one of 15 companies grouped under it. 297 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 16, 2026.

Our grouping of 16 registry names, not the registry’s. See them and correct one ↓

Compare AstraZeneca with Merck and Bristol-Myers Squibb →

Pipeline: 118 programs

Each counted once: 104 with a study AstraZeneca leads registered in the last two years, 14 more from AstraZeneca's own pipeline.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)
  • Named by AstraZeneca only (no registered study yet; not in the 118)

The 5 of 28 with the most live studies.

Program
rilvegostomigPhase 3 · AstraZeneca: Phase 3 · 22 live · Carcinoma, Non-Small-Cell Lung · primary completion May 2027☆ Track
datopotamab deruxtecanPhase 3 · 20 live · Carcinoma, Non-Small-Cell Lung · primary completion Jan 2027☆ Track
tremelimumabPhase 3 · 18 live · Carcinoma, Non-Small-Cell Lung · primary completion Nov 2026☆ Track
volrustomigPhase 3 · AstraZeneca: Phase 3 · 16 live · Carcinoma, Non-Small-Cell Lung · primary completion Jan 2027☆ Track
Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012FPhase 3 · AstraZeneca: Phase 3 · 12 live · Multiple Myeloma · primary completion Feb 2027☆ Track

23 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of AstraZeneca’s own registered studies; “AstraZeneca says” is its pipeline, which lists phases by indication. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

5 of AstraZeneca’s programs have a dated deal behind them: 4 brought in, 1 developed with a partner. Each from the companies’ own releases and filings, linked; the registry does not record them.

Brought in 4

Developed with a partner 1

What it is testing

The drugs AstraZeneca’s studies test, most open studies first — 400 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 400; every drug is on its own page, and each page lists its sponsors.

Coming up

169 of AstraZeneca’s studies under way reach primary completion within a year, 43 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 8N’26
  2. 18D
  3. 14J’27
  4. 14F
  5. 11M
  6. 15A
  7. 13M
  8. 17J
  9. 11J
  10. 12A
  11. 7S
  12. 14O
  13. 15N

The 12 nearest

Show 7 more

Add all 169 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

Newly registered14

Show 9 more

All 4,195 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now2977%Recruiting 266 · Not yet recruiting 29 · Enrolling by invitation 2
  • Under way, not recruiting2757%
  • Completed3,21277%
  • Stopped early3899%Terminated 303 · Withdrawn 78 · Suspended 8
  • Status unknown or other221%No longer available 9 · Approved for marketing 8 · Status unknown 4 · Available 1

Phase

Where

Over the years

  1. 07
  2. 31508
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 15226

By the year each study started; 639 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to AstraZeneca.

  • AstraZeneca
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3,503 studies
  • MedImmune LLC
    Acquired — became part of AstraZeneca, Jun 1, 2007 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    270 studies →
  • Alexion Pharmaceuticals, Inc.
    Acquired — became part of AstraZeneca, Jul 21, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    255 studies →
  • Pearl Therapeutics, Inc.
    Acquired — became part of AstraZeneca, Jun 27, 2013 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    42 studies →
  • Acerta Pharma BV
    Acquired — became part of AstraZeneca, Feb 2, 2016 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    41 studies →
  • Ardea Biosciences, Inc.
    Acquired — became part of AstraZeneca, Jun 19, 2012 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    36 studies →
  • Portola Pharmaceuticals
    Acquired — became part of AstraZeneca, Jul 21, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    23 studies →
  • ZS Pharma, Inc.
    Acquired — became part of AstraZeneca, Dec 17, 2015 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • Fusion Pharmaceuticals Inc.
    Acquired — became part of AstraZeneca, Jun 4, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • AstraZeneca Turkey
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Gracell Biotechnologies (Shanghai) Co., Ltd.
    Acquired — became part of AstraZeneca, Feb 22, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • CinCor Pharma, Inc.
    Acquired — became part of AstraZeneca, Feb 24, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • MedImmune Ltd
    Acquired — became part of AstraZeneca, Jun 22, 2006 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Syntimmune, Inc.
    Acquired — became part of AstraZeneca, Jul 21, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Aviron LLC
    Acquired — became part of AstraZeneca, Jun 1, 2007 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • LogicBio Therapeutics, Inc
    Acquired — became part of AstraZeneca, Nov 16, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions AstraZeneca leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Show all 96 areas
Leukemia, Lymphocytic, Chronic, B-Cell41Lupus Erythematosus, Systemic41Hyperkalemia37Hemoglobinuria, Paroxysmal35Acute Coronary Syndrome34Depressive Disorder, Major33Colorectal Neoplasms29Renal Insufficiency29Stomach Neoplasms29Depression27Gout26Hypophosphatasia25Heartburn24Carcinoma, Hepatocellular23Lymphoma22Alzheimer Disease21Coronary Artery Disease21Small Cell Lung Carcinoma21Atherosclerosis20Hyperlipidemias20Pain20Patient Compliance20Squamous Cell Carcinoma of Head and Neck20Atypical Hemolytic Uremic Syndrome19Carcinoma19Lymphoma, Non-Hodgkin19Melanoma19Myasthenia Gravis19Pancreatic Neoplasms19Biliary Tract Neoplasms18Diabetes Mellitus, Type 118Non-alcoholic Fatty Liver Disease18Urinary Bladder Neoplasms18Bronchial Diseases17Coronary Disease17Endometrial Neoplasms17Head and Neck Neoplasms17Leukemia17Lymphoma, Follicular17Myocardial Infarction17Stomach Ulcer17Emphysema16Multiple Myeloma16Carcinoma, Renal Cell15Duodenal Ulcer15Lymphoma, Mantle-Cell15Respiration Disorders15Triple Negative Breast Neoplasms15Psychotic Disorders14Respiratory Syncytial Virus Infections14Rhinitis, Allergic, Seasonal14Crohn Disease13Leukemia, Myeloid, Acute13Lymphoma, B-Cell13Osteomalacia13Wolman Disease13Bronchitis, Chronic12Hemorrhage12Hypertriglyceridemia12Lymphoma, Large B-Cell, Diffuse12Neurofibromatosis 112Rhinitis, Allergic12Bronchiolitis Obliterans Syndrome11Esophagitis, Peptic11Hepatolenticular Degeneration11Kidney Diseases11Liver Cirrhosis11Metabolic Diseases11Neuromyelitis Optica11Pneumonia11Fallopian Tube Neoplasms10Liver Neoplasms10

Studies

Recruiting first, then most recently updated. Showing 50 of 4,195. Browse all 4,195 →